Skip to main content
    T

    The Cigna Group (CI)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $300.14
    +3.14 (+1.06%)

    Market Cap: $78.26B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    The Cigna Group (CI) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    The Cigna Group (CI) trades at 9.5x trailing earnings and 0.3x sales. Its P/E of 9.5x is below its 5-year median of 11.5x. Its forward P/E is 8.9x. The median P/E across 12 similar companies is 22.0x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 6.7% higher over the next year. Its free cash flow yield is 10.5%.

    MultipleValue
    P/E (trailing)9.5x
    Forward P/E8.9x
    Price to sales0.3x
    Price to book1.8x
    EV/EBITDA11.6x
    Price to FCF9.6x
    EV/FCF17.9x
    PEG0.8
    FCF yield10.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 20.8% below 12.0x, its P/S is 40.0% below 0.5x and its P/B is in line.

    MultipleCurrent5-year median10-year median
    P/E9.5x11.5x12.0x
    P/S0.3x0.4x0.5x
    P/B1.8x1.8x1.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 9.2x in 2025 to 19.4x in 2017. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$275.239.2x0.3x1.8x
    2024$276.1410.1x0.3x1.9x
    2023$299.4511.9x0.5x1.9x
    2022$331.3414.3x0.6x2.3x
    2021$229.6311.2x0.4x1.6x
    2020$208.1811.3x0.5x1.5x
    2019$204.4912.0x0.5x1.7x
    2018$189.9213.3x1.0x1.1x
    2017$203.0919.4x1.2x3.7x
    2016$133.3916.4x0.9x2.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CI

    What is CI's forward P/E ratio?

    The Cigna Group has a forward P/E ratio of 8.9x.

    Is CI stock overvalued?

    GNG's valuation label for CI is Undervalued. Its P/E of 9.5x compares with a median of 22.0x across 12 similar companies.

    What is CI's price to sales ratio?

    The Cigna Group has a price to sales ratio of 0.3x.

    What is The Cigna Group's average P/E ratio over 5 years?

    The Cigna Group's median P/E over the last 5 years is 11.5x, from 60 month-end values through Oct 2026.

    What is CI's PEG ratio?

    The Cigna Group has a PEG ratio of 0.8.